Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
4.580
+0.140 (3.15%)
At close: Mar 27, 2026
HKG:1066 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,067 | 2,002 | 2,764 | 2,276 |
Depreciation & Amortization | 971.8 | 911.7 | 803.14 | 736.67 |
Loss (Gain) From Sale of Assets | -2.91 | 2.15 | -60.92 | 2.93 |
Asset Writedown & Restructuring Costs | 0.17 | 9.7 | 10.81 | - |
Loss (Gain) From Sale of Investments | -22.93 | 21.48 | -131.03 | -3.32 |
Loss (Gain) on Equity Investments | -74.77 | -76.86 | -75.11 | -69.46 |
Stock-Based Compensation | 36.02 | 55.46 | 91.77 | 76.49 |
Provision & Write-off of Bad Debts | 8.81 | 5.34 | 33.93 | 25.74 |
Other Operating Activities | 98.84 | 182.88 | -20.75 | 235.3 |
Change in Accounts Receivable | -398.14 | -234.75 | -807.33 | -44.88 |
Change in Inventory | -78.04 | -202.09 | -538.7 | -180.41 |
Change in Accounts Payable | 131.55 | -175.27 | 455.83 | -72.76 |
Change in Unearned Revenue | -47.02 | 61.02 | 67.6 | 37.28 |
Change in Other Net Operating Assets | 66.5 | 58.43 | -220.29 | 14.41 |
Operating Cash Flow | 2,790 | 2,799 | 2,295 | 3,087 |
Operating Cash Flow Growth | -0.31% | 21.95% | -25.65% | 10.70% |
Capital Expenditures | -598.05 | -647.58 | -1,070 | -1,120 |
Sale of Property, Plant & Equipment | 1.33 | 6.74 | 6.68 | 49.19 |
Cash Acquisitions | - | -43.22 | - | -10.29 |
Divestitures | - | 0.59 | 26.92 | - |
Sale (Purchase) of Intangibles | -49.39 | -38.09 | -43.67 | -46.2 |
Investment in Securities | -228.14 | 18.6 | -216.15 | -34.48 |
Other Investing Activities | -230.18 | -678.18 | -1,272 | -359.31 |
Investing Cash Flow | -1,104 | -1,389 | -2,547 | -1,518 |
Long-Term Debt Issued | 2,837 | 392.7 | 967.94 | 519.01 |
Total Debt Issued | 2,837 | 392.7 | 967.94 | 519.01 |
Long-Term Debt Repaid | -2,987 | -802.22 | -907.4 | -742.28 |
Total Debt Repaid | -2,987 | -802.22 | -907.4 | -742.28 |
Net Debt Issued (Repaid) | -149.67 | -409.51 | 60.55 | -223.27 |
Issuance of Common Stock | - | - | - | 261.33 |
Repurchase of Common Stock | -73.91 | -36.53 | -35.25 | -72.86 |
Common Dividends Paid | -870.59 | -732.63 | -741.64 | -653.29 |
Other Financing Activities | -501.77 | -979.18 | -304.62 | 140.17 |
Financing Cash Flow | -1,596 | -2,158 | -1,021 | -547.93 |
Foreign Exchange Rate Adjustments | 55.8 | 24.33 | 96.16 | -54.44 |
Net Cash Flow | 145.42 | -723.59 | -1,177 | 966.35 |
Free Cash Flow | 2,192 | 2,151 | 1,225 | 1,967 |
Free Cash Flow Growth | 1.91% | 75.63% | -37.72% | 4.56% |
Free Cash Flow Margin | 16.75% | 16.26% | 8.91% | 14.89% |
Free Cash Flow Per Share | 0.48 | 0.47 | 0.27 | 0.43 |
Cash Interest Paid | 210.56 | 258.18 | 184.62 | 127.11 |
Cash Income Tax Paid | 508.64 | 344.19 | 486.49 | 481.43 |
Levered Free Cash Flow | 1,636 | 968.17 | 349.83 | 802.5 |
Unlevered Free Cash Flow | 1,792 | 1,139 | 469.46 | 890.28 |
Change in Working Capital | -291.73 | -315.23 | -1,121 | -193.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.